Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives
about
Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 SignalingThe YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts.Colorectal carcinogenesis--update and perspectives.Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis.Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsInhibition of protein phosphatase 5 (PP5) suppresses survival and growth of colorectal cancer cells.Targeted therapy: resistance and re-sensitization.Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer?Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene.Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer.
P2860
Q28546382-E73FA57A-20F0-43EB-8841-F27B4EC9E663Q33588163-CF512108-071B-4B13-9073-A60511F42124Q34558883-E51C966C-287B-43F5-AD4C-6249F8F0F68AQ34667352-B8114B72-033D-45EB-8471-8673AB8C6746Q35068706-4F31FD49-3D02-4F22-9180-FCCCA0F22E2CQ35550214-A66E15EE-FD35-4628-9958-F139E3D8B633Q35673201-30AD47DF-5586-43D6-BFE8-59E1029F1426Q38947186-13EE61D7-AEE4-467D-B03D-7E7F2F82FED1Q41356511-CE38AE19-3EFF-4888-8B48-83AB8C6BF652Q47594858-F60BA410-64C2-45A4-8F46-B5F236F90851Q52582448-D12A1782-95C0-4043-A09E-57F1886A3DF0Q55347051-0DEB47D6-E240-4A4F-B46A-E9BF4E240CBD
P2860
Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Anti-angiogenic therapies for ...... urrent and future perspectives
@ast
Anti-angiogenic therapies for ...... urrent and future perspectives
@en
Anti-angiogenic therapies for ...... urrent and future perspectives
@nl
type
label
Anti-angiogenic therapies for ...... urrent and future perspectives
@ast
Anti-angiogenic therapies for ...... urrent and future perspectives
@en
Anti-angiogenic therapies for ...... urrent and future perspectives
@nl
prefLabel
Anti-angiogenic therapies for ...... urrent and future perspectives
@ast
Anti-angiogenic therapies for ...... urrent and future perspectives
@en
Anti-angiogenic therapies for ...... urrent and future perspectives
@nl
P2860
P50
P356
P1476
Anti-angiogenic therapies for ...... urrent and future perspectives
@en
P2093
Inês Marques
P2860
P304
P356
10.3748/WJG.V19.I44.7955
P407
P577
2013-11-28T00:00:00Z